SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Are On The Horizon
Virginia Retirement System disclosed SLS and IBRX stakes worth nearly $909,000 combined. The $124 billion fund ranks as…
Is It Too Late To Consider ImmunityBio (IBRX) After The Recent 181% Monthly Surge?
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. If…